S
Shield Therapeutics Plc
Profile managed by Bizz IdShield Therapeutics
Reino Unido
11-50 employees
2008
Description
Shield Therapeutics plc is a commercial-stage specialty pharma company headquartered in Gateshead, listed on AIM and OTCQB. Focused on iron deficiency with its lead product Accrufer®/Feraccru® (ferric maltol). Approved in the US (Accrufer®) and EU/UK (Feraccru®), with exclusive IP rights to mid-2030s. Total 2024 sales of $17.5M.